Literature DB >> 2013180

Negative U wave during percutaneous transluminal coronary angioplasty.

H Yano1, Y Hiasa, T Aihara, Y Nakaya, H Mori.   

Abstract

To clarify the clinical significance of the negative U wave during acute myocardial ischemia, the appearance of the U wave and ST-segment elevation on electrocardiography during percutaneous transluminal coronary angioplasty (PTCA) of the left anterior descending artery (LAD group: 11 patients) or right coronary artery (RCA group: 18 patients) was studied. During PTCA, U-wave inversion (newly developed negative U wave, and increased negativity of the pre-existing negative U wave) was observed in 37 (90%) of 41 patients in the LAD group and in 16 (89%) of 18 patients in the RCA group. The incidence of ST-segment elevation was similar to that of U-wave inversion; however, U-wave inversion appeared before detectable ST-segment elevation in 20 patients (49%) in the LAD group and in 4 patients (22%) in the RCA group. Moreover, U-wave inversion was observed frequently in a wider range of leads than ST-segment elevation. These results suggest that the U wave is a more sensitive indicator of myocardial ischemia than ST-segment elevation in some patients, and that a negative U wave may be produced by a different mechanism than that which produces ST-segment deviation, although both are related to myocardial ischemia.

Entities:  

Mesh:

Year:  1991        PMID: 2013180     DOI: 10.1002/clc.4960140311

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  2 in total

1.  How epicardial U-wave changes are reflected in body surface precordial electrocardiograms in anterior or inferoposterior myocardial ischaemia during coronary angioplasty.

Authors:  H Kataoka; S Yano; A Tamura; Y Mikuriya
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

2.  Electrocardiographic T- and U-wave discordance.

Authors:  Michael G Reinig; Robert Harizi; David H Spodick
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-01       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.